Impact of cilostazol on prevention of late failure of autologous vein grafts.
暂无分享,去创建一个
A. Guntani | S. Yamashita | S. Mii | S. Kuma | Kiyoshi Tanaka | J. Okazaki | M. Ishida | Sho Yamashita
[1] H. Sillesen,et al. Rivaroxaban in Patients with Symptomatic Peripheral Artery Disease after Lower Extremity Bypass Surgery with Venous and Prosthetic Conduits. , 2022, Journal of vascular surgery.
[2] V. Aboyans,et al. Antithrombotic Therapy in Lower Extremity Artery Disease. , 2020, Current vascular pharmacology.
[3] S. Berceli,et al. Heterogeneous and dynamic lumen remodeling of the entire infrainguinal vein bypass grafts in patients. , 2020, Journal of vascular surgery.
[4] John V. White,et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. , 2019, Journal of vascular surgery.
[5] L. Dubois,et al. The effect of gender on outcomes after lower extremity revascularization , 2016, Journal of Vascular Surgery.
[6] M. Uematsu,et al. Effect of Cilostazol Following Endovascular Intervention for Peripheral Artery Disease , 2015, Angiology.
[7] D. Palombo,et al. The Role of Oral Vitamin K Antagonists in the Outcome of Infrainguinal Bypass Procedures , 2014, Angiology.
[8] R. Larson,et al. Cilostazol is associated with improved outcomes after peripheral endovascular interventions. , 2014, Journal of vascular surgery.
[9] O. Iida,et al. Impact of cilostazol on angiographic restenosis after balloon angioplasty for infrapopliteal artery disease in patients with critical limb ischemia. , 2012, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[10] Daniel J. Bertges,et al. The influence of gender on functional outcomes of lower extremity bypass. , 2012, Journal of vascular surgery.
[11] M. Rotondo,et al. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. , 2010, Journal of vascular surgery.
[12] S. Lipsitz,et al. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. , 2009, Journal of vascular surgery.
[13] F. Kudo,et al. Cilostazol suppresses neointimal hyperplasia in canine vein grafts , 2009, Surgery Today.
[14] M. Banach,et al. Does Gender Influence the Patency of Infrainguinal Bypass Grafts? , 2008, Angiology.
[15] R. J. Valentine,et al. The effect of anticoagulation therapy and graft selection on the ischemic consequences of femoropopliteal bypass graft occlusion: results from a multicenter randomized clinical trial. , 2002, Journal of vascular surgery.
[16] Ji Min Kim,et al. Thirty-day vein remodeling is predictive of midterm graft patency after lower extremity bypass. , 2013, Journal of vascular surgery.